Background Acute otitis media (AOM) is a common self-limiting infection where antibiotics confer limited benefit. Other treatments, such as anti-inflammatory agents have been proposed as an alternative to antibiotics, but no high-quality clinical trials have tested this.
Results
We distributed 2,694 questionnaires through conferences, primary care/hospital visits, and by mail-list group. Of 492 questionnaires received (response rate 18%), 352 were from eligible clinicians. Most clinicians diagnosed AOM by using an otoscope (64-91%). Tympanometry was used by a quarter of ENT specialists. Amoxicillin-clavulanate was the most common antibiotic for AOM, prescribed by pediatricians and ENT specialists, whilst most GPs prescribed amoxicillin. Clinical scenarios indicated most ENT specialists (88%) would prescribe antibiotics and most pediatricians (54%) would choose expectant observation by withholding antibiotics for mild AOM. Almost half of clinicians would consider using corticosteroids in a trial.
Conclusion
Most clinicians would prescribe antibiotics for mild AOM. However, slightly over half of pediatricians would solely choose expectant observation. Adequate numbers of potential participating clinicians, who would consider using corticosteroids, make our proposed corticosteroids trial for AOM feasible. We found gaps between clinical practice and evidence requiring further investigation to improve AOM management in Indonesia. 
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A ntibiotics are commonly used for treating infectious diseases, including acute otitis media (AOM) in children. 1, 2 International guidelines recommend expectant observation for mild AOM, with antibiotics only given for severe cases. 3, 4 Although antibiotics are effective for AOM, their effects in improving pain and middle ear effusion are weak, they have potentially harmful side effects, and may lead to antibiotic resistance. 5, 6 Currently, there are two conflicting Indonesian guidelines for AOM. One recommends antibiotics for both mild and severe AOM, while the other recommends antibiotics only for severe cases (although 'severe' is not clearly defined). 7, 8 This potentially contributes to high use of antibiotics in the management of AOM in Indonesia, thereby increasing the risk of antibiotic resistance and other side effects. 5, 9, 10 Finding alternative treatment options could be one way to mitigate the risk of antibiotic resistance. Theoretical considerations suggest that the anti-inflammatory effect of corticosteroids might reduce symptoms. 1 Conflicting evidence on the potential benefits requires a large randomized placebocontrolled trial (RCT) to test efficacy. 12, 13 We plan to undertake a large RCT in Indonesia to further investigate this issue.
To date, there is no available data on the current AOM management for children in Indonesia. However, there have been several studies surveying the management of AOM in other countries. [14] [15] [16] A survey study in Turkey showed pediatricians were likely to prescribe antibiotics (60%) and analgesics (e.g., acetaminophen, ibuprofen) for children with AOM. 14 Surveys in India and Israel showed most ENT specialists prescribed antibiotics for AOM (62-98%). Analgesics and decongestants and/or antihistamines were also commonly prescribed. Most ENT specialists in India used an otoscope as a diagnostic tool for AOM, whilst a microscope was more preferable in Israel. 15, 16 We identified the current management, particularly with regards to prescribing antibiotics for AOM in three cities in Indonesia. This survey study was done to help us identify existing gaps between clinical practice and evidence in the management of AOM in Indonesia. Our survey was also designed to gauge clinicians' willingness to use corticosteroids in a future, randomized trial.
Methods
This study primarily aimed to identify the current management of AOM among clinicians. It also identified the feasibility of a proposed clinical trial to test corticosteroids for AOM in children. We conducted a cross-sectional study for our survey (April -August 2016). Our eligibility criteria were clinicians from three specialties (general practitioners, pediatricians, and ENT specialists) working in primary/secondary or tertiary healthcare facilities in Jakarta, Depok, and Bekasi, Indonesia. We established clinicians' specialties and email addresses from the national professional organizations of general practitioners (Indonesian Medical Association), pediatricians (Indonesian Pediatric Society), and ENT specialists (Indonesian Otorhinolaryngology Head and Neck Surgery Society). We then distributed paperbased questionnaires through workshops, conferences, primary healthcare and hospital visits. We also distributed electronic-based questionnaires through mailing lists of primary care clinician graduates from two medical schools in Jakarta (Universitas Indonesia and Universitas Pembangunan Nasional Veteran), identified by alumni and colleagues.
We invited participation in a 10-minute presentation at the following workshops and conferences: (i) The Indonesian National Committee for the Preven- (29-30 May 2016) . We distributed the questionnaires at the registration table on the first day of the workshops or conferences and collected the questionnaires at the end of the events.
We identified several primary healthcare clinics and hospitals located in Jakarta, Depok, and Bekasi that were conveniently accessible. We contacted the heads or directors of the appointed healthcare facilities and distributed the questionnaires to the emergency, pediatric, and otorhinolaryngology departments. We collected the questionnaires at most 4 weeks after their distribution, unless completed earlier.
Consenting clinicians typically completed the questionnaires in 10-20 minutes (Appendix 1). It had 3 sections: 1) current management of AOM in children, including diagnostic treatment items; 2) 3 clinical scenarios [(a.) a child aged < 2 years with mild AOM; (b.) a child aged ≥ 2 years with mild AOM; and (c.) an older child with recurrent and bilateral AOM] in which respondents were invited to describe their management ( Table 1) ; and 3) a feasibility survey to identify the number of pediatric AOM patients and clinicians who might be willing to participate in our clinical trial on corticosteroids as an alternative treatment for AOM.
We did not formally determine a sample size estimate. We used convenience sampling based on ease of accessibility to the healthcare facilities and clinicians who attended workshops and conferences specifically for general practitioners, pediatricians, and ENT specialists. The results of this study are reported as the percentage of clinicians in each category of responses. We used Chi-square test to identify the differences between specialty groups using IBM SPSS Statistics 23 software. All proportions are expressed from respondents who answered that question in the questionnaires.
This study protocol was reviewed and approved by the Ethics Committee of the Universitas Indonesia Medi- cal School and Bond University Human Research Ethics Committee. We provided a paper-and electronic-based information sheet and consent form to all respondents. Consent was received in written form and the consent process was free of coercion. All information obtained from the respondents was treated as confidential.
Results
Of 2,694 questionnaires distributed, 492 were returned (response rate 18%). Of these, 445 (90%) participated in the survey, Figure 1 . There were 352 clinicians who responded (general practitioners 81%, pediatricians 10%, and ENT specialists 9%) and they were based at primary/secondary (44%) and tertiary healthcare (54%) facilities (no response 2%) in Jakarta (82%), Depok (10%), and Bekasi (8%), our target regions. Most were young, <31 years (44%), and female (67%). A total of 705 children with AOM visited 352 clinicians over a period of seven days prior to answering the questionnaire. Most clinicians had less than three AOM cases during this period (75%), and most of these children were between two and five years of age. ENT specialists had more AOM cases (three to five cases) per week compared to general practitioners and pediatricians.
Most clinicians diagnosed AOM by using an otoscope (64-91%) ( Table 2) . Three quarters of ENT specialists and 9% of general practitioners used an endoscope. Pediatricians did not use an endoscope. A quarter of ENT specialists, but very few pediatricians (3%) or general practitioners (1%), used tympanometry to identify middle ear effusion. Few clinicians (0-6%) used a pneumatic otoscope, audiometry (0-9%), or tympanocentesis (0-3%) to diagnose AOM.
Amoxicillin-clavulanate was the most common antibiotic prescribed by ENT specialists (58%), pediatricians (46%), and general practitioners (16%) ( Table 2) . Amoxicillin was the second most common antibiotic prescribed by general practitioners (43%) and pediatricians (37%), whilst ENT specialists prescribed cefixime as the second common antibiotics for AOM (23%). Azithromycin (0-13%), cefadroxil (0-9%), erythromycin (3%), ampicillin (0-3%), and cotrimoxazole (0-3%) were the least common antibiotics prescribed for AOM. General practitioners (66%) mostly prescribed amoxicillin for three to five days, whilst ENT specialists (56%) and pediatricians (54%) prescribed amoxicillin-clavulanate for more than five days.
The clinicians' treatment choices for the three clinical scenarios are shown in Table 3 . In the first scenario, 88% of ENT specialists would prescribe antibiotics for AOM, followed by general practitioners (71%) and pediatricians (57%). More ENT specialists (44%) would prescribe corticosteroids when compared to other specialties (general practitioners 30%; pediatricians 23%). In the second scenario, 66% of ENT specialists would prescribe antibiotics, followed by general practitioners (52%) and pediatricians 
*One missing data in general practitioner group **Total 281 general practitioners and 31 ENT specialists provided their options of antibiotic types for AOM † General practitioners chose amoxicillin (77%, 17/22), followed by cefixime (32%, 6/22) and cefadroxil (32%, 6/22) in the multiple antibiotic prescription group. ‡ ENT specialist did not mention any antibiotic by name but only reported 'depends on the condition'. § Pediatricians chose cefixime (100%, 2/2), followed by amoxicillin (50%, 1/2) and amoxicillin-clavulanate (50%, 1/2) in the multiple antibiotic prescription group. (6) *Clinicians may choose more than one treatment option (46%). Thirty-seven per cent of ENT specialists and only up to quarter of general practitioners (26%) and pediatricians (20%) would choose corticosteroids.
In the third scenario, 84% of ENT specialists would prescribe antibiotics for AOM, followed by general practitioners (61%) and pediatricians (57%).
Corticosteroids were more likely to be prescribed by ENT specialists (44%) compared to other specialties (general practitioners 34%, pediatricians 31%). Clinicians would mostly prescribe acetaminophen (59-89%), decongestant/antihistamine (69-91%), and antibiotics (57-88%) for a young child with mild AOM (Scenario 1) compared with other treatment (e.g., ibuprofen, corticosteroids, topical antibiotics, or topical analgesics). From all clinical scenarios, ENT specialists were more likely to prescribe corticosteroids (37-44%) and were less likely to choose expectant observation (25-28%), whereas pediatricians (46-57%) followed by general practitioners (47-49%) were more likely to choose expectant observation compared to ENT specialists. However, as clinicians may choose more than one treatment for the clinical scenario section, there were respondents who chose both expectant observation and antibiotics, which by definition should be mutually exclusive. By identifying those who solely chose expectant observation by withholding antibiotic treatment, pediatricians (43-54%) were still more likely to choose expectant observation compared to other specialties in all three scenarios. The rate of corticosteroid prescribed by pediatricians and general practitioners ranged from 20% to 34% across the three scenarios. A significant difference between specialty groups was identified in the first scenario, where pediatricians were significantly less likely to prescribe antibiotics (P=0.024) compared to general practitioners and ENT specialists, and in the third scenario where ENT specialists were more likely to prescribe antibiotics (P=0.026) compared to other specialties. With regards to prescribing antibiotics in each scenario among these specialties, ENT specialists were more likely to prescribe antibiotics compared to other specialties, particularly in the first and third scenarios.
As shown in Figure 1 , of the 352 clinicians from Jakarta, Depok, and Bekasi, 171 respondents (49%) indicated their willingness to participate in our proposed clinical trial testing corticosteroids as an alternative treatment for AOM in children. Their characteristics were similar to the whole survey sample. They managed 443 children with AOM in a week. Most clinicians had less than three cases of AOM during this period (75%), with most of these children aged older than five years. ENT specialists had more AOM cases (three to five cases) per week compared to other specialties. These clinicians had a similar practice in the management of AOM and responses to clinical scenarios to the whole sample. Up to 44% of clinicians, mostly ENT specialists, would consider using corticosteroids in a trial.
Discussion
Our sample of clinicians who worked in Jakarta, Depok, and Bekasi, reported that they mostly diagnosed AOM by using an otoscope. Most general practitioners would prescribe amoxicillin for a short duration (3-5 days), whilst ENT specialists and pediatricians were more likely to prescribe amoxicillin-clavulanate for a longer duration. Clinical scenario results showed there was a high rate of antibiotics prescribed for mild AOM. Up to 44% of clinicians would have prescribed corticosteroids for children with AOM. Both corticosteroids and antibiotics were mostly prescribed by ENT specialists in the scenarios. There is no clear justification for a high rate of antibiotic prescribing by ENT specialists. As ENT specialists saw more patients with AOM in the sampled week compared to other specialties, their contribution to antibiotic prescribing would be higher and, therefore, the risks correlated with antibiotic use, such as adverse events and antibiotic resistance would be increased. 5, 9, 10 Another reason for this high use was due to potential complications following AOM, such as spontaneous perforation of the tympanic membrane (15%) and persistent middle ear effusion (25%). 17, 18 High rates of antibiotic prescribing by general practitioners might be influenced by the Indonesian practice guideline recommending antibiotics for both mild and severe AOM. 7 Interestingly, we found pediatricians were less likely to prescribe antibiotics for all scenarios in the study. One potential justification for this was that international pediatrics practice guidelines do not recommend antibiotics for common colds and only recommend antibiotics for AOM with high risks (e.g., children with severe signs and symptoms, children < 2 years with bilateral AOM, or tympanic membrane perforation). 3, 4, 19 Corticosteroids and antibiotics were more likely to be prescribed for AOM in younger children and recurrent bilateral AOM. These are not entirely in accordance with the guidelines, as corticosteroids have not been recommended by any guidelines. The guidelines only recommend the use of antibiotics for children under two years of age with bilateral AOM, whilst our scenario was a case of unilateral AOM. 3 Unfortunately, few clinicians (<7%, and none of the ENT specialists) used pneumatic otoscopy, which enables the assessment of tympanic membrane mobility. 3, 20 A systematic review showed that a pneumatic otoscope performed by a skilled clinician can accurately diagnose AOM with high predictive values. It can replace tympanometry as one diagnostic tool for AOM, as the pneumatic otoscope is a more affordable. 21 Our clinical scenarios demonstrated that most clinicians would prescribe antibiotics over expectant observation for mild AOM. Evidence recommends expectant observation with sufficient pain management for mild AOM. [3] [4] [5] 9 Only 30% of AOM cases are severe and require antibiotic treatment. 5, 9 However, antibiotic prescribing rates for AOM in developed and developing countries are still relatively high. In terms of data from general practices in Australia over five years, 89% of new AOM cases were managed with antibiotics. 22 Meanwhile, data from the National Ambulatory Medical Care Survey (NAMCS) demonstrated 83.1% of children with isolated AOM were managed with antibiotics. 23 Our study demonstrated that up to 88% of clinicians would prescribe antibiotics for a mild case of AOM. The Indonesian Practice Guideline recommends antibiotics for both mild and severe AOM, which may influence the high rate of antibiotic prescribing for AOM in Indonesia. 7 A red and bulging tympanic membrane could be the other reason for antibiotic treatment in all scenarios. However, the sign of red tympanic membrane is not sensitive (18%), with a low likelihood ratio for a positive result of 1.1, regardless of its high specificity (84%). Although a bulging tympanic membrane will help make the diagnosis, it requires the combination of cloudiness and the impaired mobility of the tympanic membrane to robustly diagnose AOM. 20 Recurrent AOM was the second most common reason for antibiotic prescribing in this study. This is defined as "the occurrence of 3 or more episodes of AOM in a 6-month period or the occurrence of 4 or more episodes of AOM in a 12-month period that includes at least 1 episode in the preceding 6 months". 3 The American Academy of Pediatrics Clinical Practice Guideline does not recommend the use of prophylactic antibiotics for reducing the number of episodes of AOM in recurrent AOM cases, and yet tympanostomy tubes should be offered. 3 Systematic reviews showed that recurrent AOM is not included as one indicator for antibiotic treatment in the management of AOM. 5, 9 However, The 2014 New South Wales Guideline includes recurrent AOM into the high-risk middle ear infection category, which requires immediate antibiotic treatment. 24 The high rate of antibiotic prescribing in AOM indicates the need for alternative non-antibiotic treatment for AOM. We propose to test corticosteroids for AOM. Inflammation has been indicated as an important mechanism in AOM, despite the complexity of the pathophysiology of AOM. This involves both cellular and chemical mediators (e.g., cytokines, chemokines, mast cells, and leukotrienes). Corticosteroids could act as an anti-inflammatory agent, particularly in the middle ear, 12 and therefore reduce pain. Insufficient evidence of the effects of corticosteroids for AOM requires a large, high-quality, clinical trial to evaluate corticosteroid efficacy to improve the resolution of AOM, as a monotherapy in mild cases or as an addition to antibiotic therapy in severe cases. 12 Our feasibility survey demonstrated that there were 171 clinicians who were willing to participate in our clinical trial and who saw 443 children with AOM in a week. They also had similar practices in the management of AOM and responses to clinical scenarios to the whole sample. This study also demonstrated that a sufficient number of clinicians would consider using corticosteroids for AOM. This finding was surprising; however, this high rate could be primed by clinicians' knowledge of the nature of the upcoming clinical trial, which had been provided in the consent form and at the conference presentations prior to the completion of the questionnaires. As nearly half of the clinicians were interested in participating in our trial, it is feasible to conduct a clinical trial on corticosteroids for AOM in children in Indonesia, according to the pre-specified timeline (12 months, including a three-month follow-up).
We believe this the first survey of current practices of clinicians in the management of pediatric AOM in Indonesia, which was the strength of this study. We identified clinicians' preferred treatment options, particularly in choosing corticosteroids, expectant observation, and antibiotics. However, this study also had several limitations, including the low response rate, unclear definition of 'observation for 48 to 72 hours' as one answer option in the clinical scenario, and a narrow study-site coverage. We tried several recruitment strategies to increase the response rate, however, as participation was voluntary, it was the respondents' decision to consent and participate in this survey study. There is no gold standard for an acceptable minimum survey response rate, however, a response rate of at least 70% is desirable. 25 Nonetheless, surveys involving voluntary clinicians mostly have low response rates (< 30%). 25 There are several factors that influence the willingness of clinicians to participate in a survey study, such as concerns about disruption of their practice, time, and relevance of the survey topic. 26 A review assessing survey response rates of general practitioners from published primary care journals demonstrated that the mean response rate was 61% (95% confidence interval 59% to 63%). 27 A cross-sectional study comparing the response rates between postal and online survey of general practitioners across Australia showed low response rates for both (12.4% and < 0.1%, respectively), which were similar to our study. 28 Several contributing factors were workload of the general practitioners, increasing number of other similar surveys, and no incentives for participating general practitioners. A systematic review identifying strategies to improve response rates on postal and electronic questionnaires demonstrated that the responses were likely almost doubled when there were monetary/non-monetary incentives, recorded delivery, shorter questionnaires, and interesting survey topics. 29 We did not have any funding to provide incentives. Other weakness of the study was Wwe did not clearly define the answer option of 'observation for 48 to 72 hours' in the clinical scenarios. The option for observation for 48 to 72 hours was meant for clinicians who would choose to closely observe the AOM patients without antibiotics treatment for 48 to 72 hours. Without a clear definition, clinicians who would prescribe antibiotics, may also choose observation to see the effect of antibiotics. This would limit us to precisely identify the proportion of clinicians who would solely choose observation by withholding antibiotic treatment. As the last study weakness, this study only covered three adjacent cities in two provinces (Jakarta and a small part of West Java), which certainly does not represent the current management practice of AOM in Indonesia in general (total provinces in Indonesia is 34). To generalize these findings to the rest of Indonesia requires a national scale study that includes multiple cities (rural and urban) representing each province in Indonesia, supported by the Ministry of Health, Republic of Indonesia. Given that the selfreported nature of our study is a further limitation, a national study should collect objective data on the actual number of AOM cases (including diagnosis and treatment) from primary care or hospital patient databases. However, our purpose was to survey likely practice and participation in a proposed trial.
There is still a high rate of antibiotic prescribing among Indonesian clinicians for children with AOM. Although it has not been recommended in the guidelines, clinicians would consider using corticosteroids for AOM. Given nearly half of clinicians were interested in participating in a future trial on corticosteroids, our proposed trial is feasible. This survey demonstrated existing gaps in the management of AOM between clinical practice and evidence. It is crucial to translate scientific evidence to clinical practice to improve the quality of the AOM management in children, particularly in Indonesia, by promoting an accurate and affordable diagnostic tool for AOM, such as a pneumatic otoscope, as well as by prescribing antibiotics only for severe AOM, and offering an observation under adequate pain management for mild cases. Therefore, further investigation is required to identify other contributing factors to be able to tackle this problem comprehensively. 
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